<DOC>
	<DOC>NCT00691678</DOC>
	<brief_summary>Investigators are hoping to learn if glucosamine with chondroitin can help relieve joint pain/stiffness associated with aromatase inhibitors</brief_summary>
	<brief_title>Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<criteria>Age &gt;21 years Postmenopausal status defined as cessation of menses for &gt;1 year or FSH &gt;20 mIU/mL History of stage I, II or IIIA hormone receptorpositive breast cancer, without metastatic disease Currently taking a thirdgeneration aromatase inhibitor for at least 3 months Clinical symptoms of knee and/or hand joint pain and/or stiffness for at least 3 months prior to study entry Ongoing musculoskeletal pain/stiffness in hand and/or knee joints (50 or higher on the 100 point global assessment VAS) that started or increased since initiating aromatase inhibitor therapy, and has been present for at least 3 months. patients must agree to refrain from use of glucosamine and chondroitin from sources outside of this study If taking bisphosphonates, on a stable dose for at least 3 months and tolerating the dose. Patients must agree to refrain from initiating bisphosphonate use during the course of the study. ECOG performance status 02. Hemoglobin A1c &lt;8. Signed informed consent se of glucosamine or chondroitin within the past six months Concurrent medical/arthritic disease that could confound or interfere with evaluation of pain or efficacy including: Inflammatory arthritis (e.g., rheumatoid arthritis, systemic lupus, spondyloarthropathy, psoriatic arthritis, polymyalgia rheumatica) gout episodes of acute monarticular arthritis clinically consistent with pseudogout Paget's disease affecting the study joint a history of septic arthritis or avascular necrosis or intraarticular fracture of the study joint Wilson's disease hemochromatosis alkaptonuria primary osteochondromatosis History of significant collateral ligament, anterior cruciate ligament or meniscal injury of the index joint requiring surgery or nonweight bearing (requiring use of crutches or cane) for more than 3 weeks (minor ligamentous injury prior to 6 months is not an exclusion). History of bone fracture or surgery of the afflicted knees and/or hands within 6 months prior to study entry. AST, ALT &gt; 2x normal. Serum Creatinine of &gt; 1.8 mg/dl. Uncontrolled hypertension (Systolic Blood Pressure of &gt; 150 mm Hg or Diastolic Blood Pressure of &gt;95 mm Hg). Uncontrolled diabetes mellitus, defined as Hemoglobin A1c level of &gt; 8%.</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>aromatase inhibitor</keyword>
	<keyword>supportive care</keyword>
</DOC>